Novacyt Group Microgen Bioproducts™ SARS-CoV-2 IgG EIA
For the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions. Includes all additional reagents required to perform each test.
Additional Details:
Weight:
0.60000kg
Specification
| Calibration | Standard ELISA calibration format - Pos/neg controls included with the kit |
|---|---|
| Certifications/Compliance | CE IVD certified, DoC Documentation |
| Content And Storage | 2°C to 8°C |
| Control Sets | Both positive and negative controls |
| CE Marker | Yes |
| Detectable Analytes | SARS-CoV-2 IgG Antibodies (Nucleocapsid Protein) |
| Detection Method | Enzyme-linked immunosorbent assay; chromatography/colour change |
| Format | 96-well Plate |
| Sample Type | Human Plasma or Human Serum |
| Sensitivity | 100% - > 14 days post PCR confirmation |
| Type | Antibody ELISA |
| Formulation | Chemical compositions are found in Safety Data Sheets |
| For Use With (Application) | ELISA |
| For Use With (Equipment) | Manual OR Automated ELISA Systems & Plate Reader for Interpretation |
| Includes | Positive control 1 x 3.5 mL, Negative control 1 x 3.5 mL, Wash buffer 2 x 12 5 mL, Sample buffer 2 x 125 mL, Conjugate 1 x 60 mL, Substrate solution 1 x 60 mL, Stop solution 1 x 60 mL |
| Material | Polypropylene Plates |
| No. of Reactions | 480 |
| Organism Group | Antibodies |
| Packaging Type | Foil pouches and plastic bottles |
| Quantity | 15/Pk. |
| Sample Size | 5 μL of human plasma or human serum |
| Species | Human |
| Specificity | 0.994 |
| Sterility | Sterile |
| Target Organism Class | Antibodies/Nucleocapsid protein |
| Test Time | <1.5 hr. |